Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan

Pigment Cell Research

Volumn 13, Issue SUPPL. 8, 2000, Pages 130-134

  Tomita, Yasushi ^a   Miyamura, Yoshinori ^a   Kono, Michihiro ^b   Nakamura, Rieko ^a   Matsunaga, Jun ^c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Albinism; Dyschromatosis symmetrica hereditaria; Tyrosinase; Waardenburg syndrome

Indexed keywords

CARRIER PROTEIN; MEMBRANE PROTEIN; MONOPHENOL MONOOXYGENASE; OCA2 PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR;

ARTICLE; GENETICS; HUMAN; HYPOPIGMENTATION; JAPAN; OCULAR ALBINISM; PIEBALDISM; WAARDENBURG SYNDROME;

ALBINISM, OCULOCUTANEOUS; CARRIER PROTEINS; HERMANSKI-PUDLAK SYNDROME; HUMANS; HYPOPIGMENTATION; JAPAN; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MONOPHENOL MONOOXYGENASE; PIEBALDISM; PROTO-ONCOGENE PROTEINS C-KIT; WAARDENBURG'S SYNDROME;

EID: 0034565170     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.13.s8.23.x     Document Type: Article

References (30)

1. Tomita Y, Takeda A, Okinaga S, Tagami H, Shibahara S. Human oculocutaneous albinism caused by a single base insertion in the tyrosinase gene. Biochem Biophys Res Commun 1989;164:990-996
2. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Proc Natl Acad Sci USA 1991;88:8696-8699
3. Fleischman RA, Saltman DL, Stastny V, Zneimer S. Deletion of the c-kit proto-oncogene in the human developmental defect piebald trait. Proc Natl Acad Sci USA 1991;88:10885-10889
4. Tassabehjt M, Read AP, Newton VE, Harris R, Balling R, Gruss P, Strachan T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 1992;355:635-637
5. Baldwin CT, Hoth CF, Amos JA, da-Silva EO, Milunsky A. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 1992;355:637-638
6. Tassabehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nature Gen 1994;8:251-255
7. Tachibana M, Perez-Jurado LA, Nakayama A, Hodgkinson CA, Li X, Schneider M, Miki T, Fez J, Francke U, Arnheiter H. Cloning of MITF, the human homolog of the mouse microphthalmia gene, and assignment to human chromosome 3, region p14.1-p12.3. Human Mol Gen 1994;3:553-557
8. Puffenberger EG, Hosoda K, Washington SS, Nakano K, deWit D, Yanagisawa M, Chakravarti A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994;79:1257-1266
9. Tachibana M. A cascade of genes related to Waardenburg syndrome. J Invest Dermatol 1999;4:126-129
10. Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nature Gen 1998;18:283-286
11. Oh J, Bailin T, Fukai K, Feng GH, Ho L, Mao J, Frenk E, Tamura N, Spritz RA. Cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organlles. Nat Gen 1996;14:300-306
12. Dell'Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS. Altered trafficking of lysosomal protein in Hermansky-Pudlak syndrome due to mutations in the beta-3A subunit of the AP-3 adaptor. Mol Cell 1999;3:11-21
13. Nagel DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, Mcgrail SH, Dussault BJ Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Gen 1996;14:307-311
14. Pastural E, Barrat FJ, Dufourcq-Lagelouse R, Certain S, Sanal O, Jabado N, Seger R, Griscelli C, Fischer A, deSaint Basile G. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene. Nat Gen 1997;16:289-292
15. King R, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Bases of Inherited Disease, 7th Ed, vol. II. New York: McGraw Hill; 1995. pp. 4353-4392
16. Giebel LB, Tripathi RK, Strunk KM, Hanifin JM, Jackson CE, King RA, Spritz RA. Tyrosinase gene mutations associated with type 1B ("yellow") oculocutaneous albinism. Am J Human Gen 1991;48:1159-1167
17. King RA, Townsend D, Oetting W. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. J Clin Invest 1991;87:1046-1053
18. Giebel LB, Tripathi RK, King RA, Spritz RA. Temperature-sensitive tyrosinase in human albinism: a human homologue to the Siamese cat and the Himalayan mouse. J Clin Invest 1991;87:1119-1122
19. Lee S-T, Nicholls RD, Jong MTC, Fukai K, Spritz RA. Organization and sequence of the human P gene and identification of a new family of transport proteins. Genomics 1995;26:354-363
20. Rinchik EM, Bultman SJ, Horsthemke B, Lee ST, Strunk KM, . Spritz RA, Avidamo KM, Jong MTC, Nicholls RD. A gene for the mouse pink-eyed dilution locus and for human type II oculocutaneous albinism. Nature 1993;361:72-76
21. Kerr R, Stevens G, Manga P, Salm S, John P, Haw T, Ramsay M. Identification of P gene mutations on individuals with oculocutaneous albinism in sub-Saharan Africa. Human Gen 2000;15:166-172
22. Kobayashi T, Urabe K, Winder AJ, Jimenez-Cervantes C, Imokawa G, Brewington T, Solano F, Garcia-Borron JC, Hearing VJ. Tyrosinase-related protein 1 (TRP-1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994;13:5818-5825
23. Manga P, Kromberg JGR, Box NF, Sturm RA, Jenkins T, Ramsay M. Rufous oculocutaneous albinism in southern African blacks is caused by mutations in the TYRP1 gene. Am J Human Gen 1997;61:1095-1101
24. Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S. Molecular basis of tyrosinase-negative oculocutaneous albinism. J Biol Chem 1990;265:17792-17797
25. Matsunaga J, Dakeishi M, Shimizu H, Tomita Y. R278TER and P431L mutations of the tyrosinase gene exist with tyrosinase-necative oculocutaneous albinism. J Dermatol Sci 1996;13:134-139
26. Matsunaga J, Tomita Y, Tagami H. Detection of point mutations in human tyrosinase gene by improved allele-specific amplification. Exp Dermatol 1995;4:377-381
27. Matsunaga J, Dakeishi-Hara M, Miyamura Y, Nakamura E, Tanita M, Satomura K, Tomita Y. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper. Dermatology 1998;196:189-193
28. Matsunaga J, Dakeishi M, Shimizu H, Nishikawa T, Aozaki R, Tomita Y. Mutations in the tyrosinase gene causing tyrosinase-negative oculocutaneous albinism in Japanese patients. In: Hori Y, Hearing VJ, Nakayama J. Melanogenesis and Malignant Melanoma: Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis and Treatment. Amsterdam: Elsevier Science; 1996. pp. 3-6
29. Matsunaga J, Dakeishi-Hara M, Tanita M, Nindl M, Nagata Y, Nakamura E, Miyamura Y, Kikuchi K, Furue M, Tomita Y. A splicing mutation of the tyrosinase gene causes yellow oculocutaneous albinism in Japanese patients with a pigmented phenotype. Dermatology 1999;199:124-129
30. Kono M, Miyamura Y, Matsunaga J, Tomita Y. Exclusion of linkage between dyschromatosis symmetrica hereditaria and chromosome 9. J Dermatol Sci 2000;22:88-95